Radicicol, an inhibitor of Hsp90, enhances TRAIL-induced apoptosis in human epithelial ovarian carcinoma cells by promoting activation of apoptosis-related proteins
Authors:
- 29 July 2011
- journal article
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 359 (1-2) , 33-43
Abstract
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces apoptosis in various cancer cells. Hsp90 is known to be involved in cell survival and growth in tumor cells. Nevertheless, Hsp90 inhibitors exhibit a variable effect on the cytotoxicity of anticancer drugs. Furthermore, the combined effect of Hsp90 inhibitors on TRAIL-induced apoptosis in epithelial ovarian cancer cells has not been determined. To assess the ability of an inhibitor of Hsp90 inhibitor radicicol to promote apoptosis, we investigated the effect of radicicol on TRAIL-induced apoptosis in the human epithelial ovarian carcinoma cell lines OVCAR-3 and SK-OV-3. TRAIL induced a decrease in Bid, Bcl-2, Bcl-xL, and survivin protein levels, increase in Bax levels, loss of the mitochondrial transmembrane potential, cytochrome c release, activation of caspases (-8, -9, and -3), cleavage of PARP-1 and an increase in the tumor suppressor p53 levels. Radicicol enhanced TRAIL-induced apoptosis-related protein activation, nuclear damage and cell death. These results suggest that radicicol may potentiate the apoptotic effect of TRAIL on ovarian carcinoma cell lines by increasing the activation of the caspase-8- and Bid-dependent pathway and the mitochondria-mediated apoptotic pathway, leading to caspase activation. Radicicol may confer a benefit in the TRAIL treatment of epithelial ovarian adenocarcinoma.Keywords
This publication has 35 references indexed in Scilit:
- Mitochondria as decision‐makers in cell deathEnvironmental and Molecular Mutagenesis, 2010
- Inhibition of 90-kD heat shock protein potentiates the cytotoxicity of chemotherapeutic agents in human glioma cellsJournal of Neurosurgery, 2010
- A Smac-mimetic sensitizes prostate cancer cells to TRAIL-induced apoptosis via modulating both IAPs and NF-kappaBBMC Cancer, 2009
- Targeting HSP90 for cancer therapyBritish Journal of Cancer, 2009
- BH3 Mimetic Obatoclax Enhances TRAIL-Mediated Apoptosis in Human Pancreatic Cancer CellsClinical Cancer Research, 2008
- Apoptotic mechanisms involved in neurodegenerative diseases: Experimental and therapeutic approachesMethods and Findings in Experimental and Clinical Pharmacology, 2008
- Protective effect of radicicol against LPS/IFN-γ-induced neuronal cell death in rat cortical neuron–glia culturesLife Sciences, 2007
- Strategies for therapeutic targeting of the p53 pathway in cancerCell Death & Differentiation, 2006
- Mitochondria: a target for cancer therapyBritish Journal of Pharmacology, 2006
- Pathways of chaperone-mediated protein folding in the cytosolNature Reviews Molecular Cell Biology, 2004